Annual Net Income
-$36.01 M
+$13.97 M+27.95%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual net profit is currently -$36.01 million, with the most recent change of +$13.97 million (+27.95%) on 31 December 2023. MLTX annual net income is now at all-time high.MLTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$35.39 M
-$11.12 M-45.84%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly net profit is currently -$35.39 million, with the most recent change of -$11.12 million (-45.84%) on 30 September 2024. Over the past year, it has dropped by -$25.96 million (-275.45%). MLTX quarterly net income is now -462.81% below its all-time high of -$6.29 million, reached on 30 September 2021.MLTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$80.77 M
-$25.96 M-47.38%
30 September 2024
Summary:
MoonLake Immunotherapeutics TTM net profit is currently -$80.77 million, with the most recent change of -$25.96 million (-47.38%) on 30 September 2024. Over the past year, it has dropped by -$35.09 million (-76.82%). MLTX TTM net income is now -147.10% below its all-time high of -$32.69 million, reached on 30 June 2021.MLTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.9% | -275.4% | -76.8% |
| 3 y3 years | - | -462.8% | -107.2% |
| 5 y5 years | - | - | - |
MLTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.9% | -462.8% | at low | -135.6% | at low |
| 5 y | 5 years | at high | +27.9% | -462.8% | at low | -147.1% | at low |
| alltime | all time | at high | +27.9% | -462.8% | at low | -147.1% | at low |
MoonLake Immunotherapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$35.39 M(+45.8%) | -$80.77 M(+47.4%) |
| June 2024 | - | -$24.27 M(+77.5%) | -$54.80 M(+34.7%) |
| Mar 2024 | - | -$13.67 M(+83.9%) | -$40.68 M(+13.0%) |
| Dec 2023 | -$36.01 M | -$7.44 M(-21.1%) | -$36.01 M(-21.2%) |
| Sept 2023 | - | -$9.43 M(-7.0%) | -$45.68 M(-1.5%) |
| June 2023 | - | -$10.14 M(+12.6%) | -$46.36 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$9.00 M(-47.4%) | -$48.34 M(-12.5%) |
| Dec 2022 | -$49.97 M | -$17.11 M(+69.2%) | -$55.22 M(+44.9%) |
| Sept 2022 | - | -$10.11 M(-16.6%) | -$38.11 M(+11.1%) |
| June 2022 | - | -$12.12 M(-23.7%) | -$34.29 M(-37.5%) |
| Mar 2022 | - | -$15.88 M(+152.5%) | -$54.85 M(+40.7%) |
| Sept 2021 | - | -$6.29 M(-80.8%) | -$38.97 M(+19.2%) |
| June 2021 | - | -$32.69 M | -$32.69 M |
FAQ
- What is MoonLake Immunotherapeutics annual net profit?
- What is the all time high annual net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual net income year-on-year change?
- What is MoonLake Immunotherapeutics quarterly net profit?
- What is the all time high quarterly net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
- What is MoonLake Immunotherapeutics TTM net profit?
- What is the all time high TTM net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM net income year-on-year change?
What is MoonLake Immunotherapeutics annual net profit?
The current annual net income of MLTX is -$36.01 M
What is the all time high annual net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual net profit is -$36.01 M
What is MoonLake Immunotherapeutics annual net income year-on-year change?
Over the past year, MLTX annual net profit has changed by +$13.97 M (+27.95%)
What is MoonLake Immunotherapeutics quarterly net profit?
The current quarterly net income of MLTX is -$35.39 M
What is the all time high quarterly net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly net profit is -$6.29 M
What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
Over the past year, MLTX quarterly net profit has changed by -$25.96 M (-275.45%)
What is MoonLake Immunotherapeutics TTM net profit?
The current TTM net income of MLTX is -$80.77 M
What is the all time high TTM net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM net profit is -$32.69 M
What is MoonLake Immunotherapeutics TTM net income year-on-year change?
Over the past year, MLTX TTM net profit has changed by -$35.09 M (-76.82%)